Giant cell tumor of the femoral neck: case report

Silva, Paulo; Amaral, Rogério Andrade do; Oliveira, Leandro Alves de; Moraes, Frederico Barra de; Chaibe, Eduardo Damasceno

doi:10.1016/j.rboe.2016.09.006

Cited by 4 publications

(4 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…37 A femoral neck GCTB did recur after 1 year. 38 A 9-year-old child with two prior GCTB recurrences of the distal femur did not recur a third time after 96 months follow up. Premature physeal closure did occur.…”

Section: Resultsmentioning

confidence: 93%

Heat treatment for giant cell tumors of bone: A systematic review

Schoutens,

Verspoor

2023

J Orthop Surg (Hong Kong)

View full text Add to dashboard Cite

This systematic review evaluates the effects of heat treatments in de novo, residual and recurrent giant cell tumors of bone (GCTB). Studies were eligible for inclusion if one of the following treatments was administered: radiofrequency ablation (RFA), microwave ablation, argon cauterization, electrocauterization and hot liquid treatment. The primary outcome was recurrence. Secondary outcomes were complications, pain, function, and quality of life. Recurrence rates for microwave ablation as an adjuvant to intralesional curettage were 0%, 4% and 10% (3 retrospective single-group studies); for argon cauterization 4%, 8% and 26% (3 cohort studies); electrocauterization 0% to 33% (8 cohort studies); and hot liquid 9.5% and 24% (2 cohort studies). Follow-up was generally ≥24 months. Data on pain, function and quality of life were scarce. Complications included infection and secondary osteoarthritis. Current evidence does not demonstrate or exclude an effect of heat treatments on recurrence in GCTB. Further research should objectify if (subgroups of) patients benefit from these treatments.

show abstract

Section: Resultsmentioning

confidence: 93%

Heat treatment for giant cell tumors of bone: A systematic review

Schoutens,

Verspoor

2023

J Orthop Surg (Hong Kong)

View full text Add to dashboard Cite

show abstract

“…Because the mesenchymal stem cell can differentiate into a wide rank of overlap tumors and the diagnosis was difficult, authors were not unified in classification. For the borderline tumor, the authors considered it as an "aggressive benign bone tumor" [16] or "aggressive benign neoplasm" [3]. Therefore, the role of immunohistochemistry was critical.…”

Section: Discussionmentioning

confidence: 99%

“…On X-ray, TPs at the PF (trochanter-neck-head), necktrochanter, trochanters, and neck were 21 (48%), 16 Biopsy was made once for 24 patients, twice for 25 patients, and three times for one patient. They were made on 44 (88%) patients before treatment.…”

Section: Table 2 Group Of Ages and Gender Related To Tumorsmentioning

confidence: 99%

Case series study: the diagnosis and treatment of fifty tumors and pseudotumors at the proximal femur

Van¹,

Cao²

2022

MedPharmRes

View full text Add to dashboard Cite

Introduction: Tumor and pseudotumor (TP) at the proximal femur (PF) can seriously affect mortality, extremity function, and body integrity. However, reports often focused on a specific tumor, not regional lesions. This study focuses on clinical findings, imaging, micro-pathology, and the treatment of all TP at the site. Methods: The study involved all patients who had a confirmed tumor or pseudotumor diagnosis at the PF. The clinical findings, X-ray, and biopsy were recorded and analyzed. Treatment was optional depending on the patient's situation and available condition of the hospital. The functional outcome, bone healing were defined at the last examination or two years of follow-up. Results: Fifty patients were involved in the study. Twenty-four patients had apparent tumors. TP at the PF, neck-trochanter, trochanters, and neck were 21 (42%), 16 (32%), 9 (18%), and 4 (8%) cases, respectively. There were 29 (58%) pathologic fractures. Biopsy was made for all patients. Twenty-three cases (46%) were malignant, and 8 (16%) cases were giant cell tumors. Thirtythree patients suffered from an operation. Ennerking's functional score was excellent, good, fair, and poor in 24 (48%), 5 (10%), 1 (2%), and 20 (40%) patients, respectively. For the last outcomes of 33 operated patients, 17 healed, three unchanged, one worse, and two dead. Conclusions: For the PF TP, the rate of malignant and pathological fracture was high. The giant cell tumor was not rare. The resection of the TP combined with grafts using ordinary fixation devices was satisfactory.

show abstract

“…Paulo silva et al [8] a similar case of proximal femur GCT where they used endoprosthesis for the proximal femur. In our case we did an extended curettage of the lesion, proximal femur nailing and packing of remaining hollow space with bone graft from iliac crest and we achieved good results.…”

Section: Discussionmentioning

confidence: 99%

A rare case of giant cell tumour in proximal femur: A case report

Mohan¹,

Kv²,

Pa³

et al. 2019

Int. J. Orthop. Sci.

View full text Add to dashboard Cite

Giant cell tumors are most common benign tumors of bone. The most common sites are distal femur, proximal tibia, distal end of radius. The proximal femur is one of rare site of Giant cell tumor. Here we present a case of giant cell tumor of proximal femur in 50 year old male. We confirmed it by biopsy and patient underwent extended curettage with bone grafting of proximal femur along with proximal femur nailing. We are presenting it as a case report.

show abstract

Giant cell tumor of the femoral neck: case report

Cited by 4 publications

References 9 publications

Heat treatment for giant cell tumors of bone: A systematic review

Heat treatment for giant cell tumors of bone: A systematic review

Case series study: the diagnosis and treatment of fifty tumors and pseudotumors at the proximal femur

A rare case of giant cell tumour in proximal femur: A case report

Contact Info

Product

Resources

About